Your browser doesn't support javascript.
loading
Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial.
Zelniker, Thomas A; Ardissino, Maddalena; Andreotti, Felicita; O'Donoghue, Michelle L; Yin, Ophelia; Park, Jeong-Gun; Murphy, Sabina A; Ruff, Christian T; Lanz, Hans J; Antman, Elliott M; Braunwald, Eugene; Giugliano, Robert P; Merlini, Piera Angelica.
Afiliação
  • Zelniker TA; Division of Cardiology, Medical University of Vienna, Austria (T.A.Z.).
  • Ardissino M; Department of Medicine, Imperial College, London, United Kingdom (M.A.).
  • Andreotti F; Fondazione Policlinico Universitario Gemelli IRCCS, Rome, Italy (F.A.).
  • O'Donoghue ML; Institute of Cardiology, Catholic University Medical School, Rome, Italy (F.A.).
  • Yin O; TIMI Study Group, Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.L.O., J.-G.P., S.A.M., C.T.R., E.M.A., E.B., R.P.G.).
  • Park JG; Daiichi Sankyo Inc, Basking Ridge, NJ (O.Y.).
  • Murphy SA; TIMI Study Group, Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.L.O., J.-G.P., S.A.M., C.T.R., E.M.A., E.B., R.P.G.).
  • Ruff CT; TIMI Study Group, Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.L.O., J.-G.P., S.A.M., C.T.R., E.M.A., E.B., R.P.G.).
  • Lanz HJ; TIMI Study Group, Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.L.O., J.-G.P., S.A.M., C.T.R., E.M.A., E.B., R.P.G.).
  • Antman EM; Daiichi Sankyo Europe GmbH, Munich, Germany (H.J.L.).
  • Braunwald E; TIMI Study Group, Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.L.O., J.-G.P., S.A.M., C.T.R., E.M.A., E.B., R.P.G.).
  • Giugliano RP; TIMI Study Group, Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.L.O., J.-G.P., S.A.M., C.T.R., E.M.A., E.B., R.P.G.).
  • Merlini PA; TIMI Study Group, Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.L.O., J.-G.P., S.A.M., C.T.R., E.M.A., E.B., R.P.G.).
Circulation ; 143(7): 673-684, 2021 02 16.
Article em En | MEDLINE | ID: mdl-33587659

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Piridinas / Fibrilação Atrial / Tiazóis / Inibidores do Fator Xa Tipo de estudo: Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Circulation Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Piridinas / Fibrilação Atrial / Tiazóis / Inibidores do Fator Xa Tipo de estudo: Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Circulation Ano de publicação: 2021 Tipo de documento: Article